v3 Template
T

ThirtyFiveBio Limited

Biotechnology / Healthcare ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$625K
Funding Rounds
1
Last Funding
2023-09-13

About ThirtyFiveBio Limited

ThirtyFiveBio is focused on developing innovative treatments, specifically oral GPR35 inhibitors, to act as a gut epithelial shield for patients with colitis.

Products & Services

Oral GPR35 Inhibitors:Designed as a gut epithelial shield for patients suffering from colitis.

Specialties

GPR35 Inhibitors Gut Epithelial Treatments Colitis Treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 625000
MR: -
FA: £495,000 (~$625,000)
FAN: 625000 		D: 2023-09-13
FD: 2023-09-13 		1 investors
Grant Latest
2023-09-13
$625K
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

James Westcott

Chief Executive Officer

LinkedIn (Pro only)
T

Tom McCarthy

Co-founder & Executive Chair

LinkedIn (Pro only)
J

Josselin Caradec

Head of Biology

LinkedIn (Pro only)
C

Chris Luckhurst

Head of Chemistry

D

Danish Memon

Lead Bioinformatician

H

Helen Carlile

Director of Operations

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

ThirtyFiveBio Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~480 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro